In addition to anti-apoptotic, migratory and invasive activities of the PCP4/PEP19 [13, 16], our results indicated the PCP4/PEP19 enhances aromatase expression in ER- SK-BR-3 human breast cancer cells. This evidence concerns the gene ESR1 and breast cancer.